Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic Lesions

NCT00640744 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis

Interventions

DRUG: Atorvastatin

Sponsor

Baylor College of Medicine

Collaborators

[object Object]